Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
University Health Network, Toronto
Meyer Children's Hospital IRCCS
Celon Pharma SA
Henan Cancer Hospital
Henan Cancer Hospital
Henan Cancer Hospital
Henan Cancer Hospital
Grupo Espanol de Investigacion en Sarcomas
Sun Yat-sen University
Sun Yat-sen University
Salarius Pharmaceuticals, LLC
Base Therapeutics (Shanghai) Co., Ltd.
Xiangya Hospital of Central South University
National Cancer Institute, Naples
Centre Leon Berard
HRYZ Biotech Co.
Regina Elena Cancer Institute
Tracon Pharmaceuticals Inc.
Centre Leon Berard
Centre Leon Berard
Instituto do Cancer do Estado de São Paulo
Sun Yat-sen University
Sun Yat-sen University
Kineta Inc.
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
Grupo Espanol de Investigacion en Sarcomas
Grupo Espanol de Investigacion en Sarcomas
Grupo Espanol de Investigacion en Sarcomas
Institut Bergonié
Ludwig-Maximilians - University of Munich
Henan Cancer Hospital
Centre Leon Berard
Genzada Pharmaceuticals USA, Inc.
Peking University Cancer Hospital & Institute
Ascentage Pharma Group Inc.
Ruijin Hospital
ImmVira Pharma Co. Ltd
Istanbul Medeniyet University
Sun Yat-sen University
Maria Sklodowska-Curie National Research Institute of Oncology
Rigshospitalet, Denmark
Samsung Medical Center
Yonsei University